Search Results - "Doggen, Carine J.M."

Early cardiopulmonary resuscitation and use of Automated External Defibrillators by laypersons in out-of-hospital cardiac arrest using an SMS alert service by Scholten, Annemieke C, van Manen, Jeannette G, van der Worp, Wim E, IJzerman, Maarten J, Doggen, Carine J.M

“…Abstract Aim To evaluate an SMS service (SMS = short message service = text message) with which laypersons are alerted to go to patients with suspected…”
Get full text

Serum Lipid Levels and the Risk of Venous Thrombosis by Doggen, Carine J.M, Smith, Nicholas L, Lemaitre, Rozenn N, Heckbert, Susan R, Rosendaal, Frits R, Psaty, Bruce M

“…OBJECTIVE—Lipids, through effects on the coagulation and fibrinolytic systems, may contribute to the development of venous thrombosis. This association has…”
Get full text

Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men by Meltzer, Mirjam E, Doggen, Carine J.M, de Groot, Philip G, Meijers, Joost C.M, Rosendaal, Frits R, Lisman, Ton

“…1 Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht 2 Department of Clinical Epidemiology, Leiden University Medical…”
Get full text

F9 Malmo, factor IX and deep vein thrombosis by Bezemer, Irene D, Arellano, Andre R, Tong, Carmen H, Rowland, Charles M, Ireland, Helen A, Bauer, Kenneth A, Catanese, Joseph, Reitsma, Pieter H, Doggen, Carine J.M, Devlin, James J, Rosendaal, Frits R, Bare, Lance A

“…1 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 2 Celera, Alameda, CA, USA 3 Department of Cardiovascular…”
Get full text

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents by Buiten, Rosaly A., Ploumen, Eline H., Zocca, Paolo, Doggen, Carine J.M., Danse, Peter W., Schotborgh, Carl E., Scholte, Martijn, van Houwelingen, K. Gert, Stoel, Martin G., Hartmann, Marc, Tjon Joe Gin, R. Melvyn, Somi, Samer, Linssen, Gerard C.M., Kok, Marlies M., von Birgelen, Clemens

“…The aim of this study was to assess the 3-year safety and efficacy of treating all-comer patients with 3 contemporary drug-eluting stents (DES). The BIO-RESORT…”
Get full text

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years by Buiten, Rosaly A., Ploumen, Eline H., Zocca, Paolo, Doggen, Carine J.M., Jessurun, Gillian A.J., Schotborgh, Carl E., Roguin, Ariel, Danse, Peter W., Benit, Edouard, Aminian, Adel, van Houwelingen, K. Gert, Schramm, Alexander R., Stoel, Martin G., Somi, Samer, Hartmann, Marc, Linssen, Gerard C.M., von Birgelen, Clemens

“…The aim of this study was to assess 2-year safety and efficacy of the current-generation thin composite-wire-strut durable-polymer Resolute Onyx…”
Get full text

Detecting Patient Deterioration Early Using Continuous Heart rate and Respiratory rate Measurements in Hospitalized COVID-19 Patients by Peters, Guido M, Peelen, Roel V, Gilissen, Vincent JHS, Koning, Mark V, van Harten, Wim H, Doggen, Carine J.M.

“…Background Presenting symptoms of COVID-19 patients are unusual compared with many other illnesses. Blood pressure, heart rate, and respiratory rate may stay…”
Get full text

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial by Ploumen, Eline H, Buiten, Rosaly A, Zocca, Paolo, Doggen, Carine JM, Aminian, Adel, Schotborgh, Carl E, Jessurun, Gillian AJ, Roguin, Ariel, Danse, Peter W, Benit, Edouard, Birgelen, Clemens von

“…Background:At 1 year, the international randomized BIONYX trial (ClinicalTrials.gov:NCT02508714) established non-inferiority regarding safety and efficacy of…”
Get full text

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: a systematic review and meta-analysis of studies by Mukete, Bertrand N, van der Heijden, Liefke C, Tandjung, Kenneth, Baydoun, Hassan, Yadav, Kapil, Saleh, Qusai A, Doggen, Carine J.M, Rafeh, Nidal Abi, Le Jemtel, Thierry H, von Birgelen, Clemens

“…Abstract Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safety issues of metallic drug-eluting stents. However,…”
Get full text

Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey by van Balveren, Jasmijn A, Verboeket-van de Venne, Wilhelmine P H G, Doggen, Carine J M, Cornelissen, Anne S, Erdem-Eraslan, Lale, de Graaf, Albert J, Krabbe, Johannes G, Musson, Ruben E A, Oosterhuis, Wytze P, de Rijke, Yolanda B, van der Sijs, Heleen, Tintu, Andrei N, Verheul, Rolf J, Hoedemakers, Rein M J, Kusters, Ron

“…Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Failure to recognize these…”
Get more information

Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups by van Dijk, Sanne H.B, Brusse-Keizer, Marjolein G.J, Effing, Tanja, van der Valk, Paul D.L.P.M, Ploumen, Eline H, van der Palen, Job, Doggen, Carine J.M, Lenferink, Anke

“…Background: Comorbidities are known to complicate disease management in patients with Chronic Obstructive Pulmonary Disease (COPD). This is partly due to lack…”
Get full text

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study) by Cannegieter, Suzanne C, Doggen, Carine J M, van Houwelingen, Hans C, Rosendaal, Frits R

“…Recent studies have indicated an increased risk of venous thrombosis after air travel. Nevertheless, questions on the magnitude of risk, the underlying…”
Get full text

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis by Meltzer, Mirjam E, Lisman, Ton, Doggen, Carine J M, de Groot, Philip G, Rosendaal, Frits R

“…Previously, we demonstrated that hypofibrinolysis, a decreased capacity to dissolve a blood clot as measured with an overall clot lysis assay, increases the…”
Get full text

TCT-357 Impact of Gender and Age on 3-Year Clinical Outcome and Chest Pain of Patients With Coronary Artery Disease Treated With Contemporary Drug-Eluting Stents: A Patient-Level Pooled Analysis by Kok, Marlies, van der Heijden, Liefke, Lowik, Marije, Zocca, Paolo, Doggen, Carine J.M, Danse, Peter, Anthonio, Rutger L, Hartmann, Marc, Linssen, Gerard C.M, Maas, Angela, Mehran, Roxana, von Birgelen, Clemens

“…Women <65 years of age reported significantly more chest pain at rest or mild exertion than men of the same age (11.7% vs. 5.9%, p=0.01), multivariate analysis…”
Get full text

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS by Huisman, Jennifer, van der Heijden, Liefke C, Kok, Marlies M, Louwerenburg, J Hans W, Danse, Peter W, Jessurun, Gillian A J, de Man, Frits H A F, Löwik, Marije M, Linssen, Gerard C M, IJzerman, Maarten J, Doggen, Carine J M, von Birgelen, Clemens

“…Data on medium-term outcome of patients with acute coronary syndrome (ACS), treated with newer-generation durable polymer drug-eluting stents (DES) in severely…”
Get full text

TCT-170 Clinical Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From DUTCH PEERS (TWENTE II) Randomized Trial by Gert van Houwelingen, K, van der Heijden, Liefke, Lam, Ming Kai, Lowik, Marije, Danse, Peter, Tjon Joe Gin, R. Melvyn, Jessurun, Gillian A, Anthonio, Rutger L, Sen, Hanim, Linssen, Gerard C.M, IJzerman, Maarten J, Doggen, Carine J.M, von Birgelen, Clemens

“…The aim of the study was to assess the safety and efficacy of percutaneous coronary interventions with two novel durable polymer-coated drug-eluting stents in…”
Get full text

A nurse-initiated pain protocol in the ED improves pain treatment in patients with acute musculoskeletal pain by Pierik, Jorien G.J., Berben, Sivera A., IJzerman, Maarten J., Gaakeer, Menno I., van Eenennaam, Fred L., van Vugt, Arie B., Doggen, Carine J.M.

“…•The nurse-initiated pain protocol improved analgesic provision and administration.•A high percentage of patients refused to take analgesics.•Protocol…”
Get full text

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial by Lam, Ming Kai, MD, Sen, Hanim, MD, van Houwelingen, K. Gert, MD, Löwik, Marije M., PhD, van der Heijden, Liefke C., MD, Kok, Marlies M., MD, de Man, Frits H.A.F., MD, PhD, Linssen, Gerard C.M., MD, PhD, Tandjung, Kenneth, MD, PhD, Doggen, Carine J.M., PhD, von Birgelen, Clemens, MD, PhD

“…Background Only limited data from large randomized clinical trials have been published on the long-term performance of second-generation drug-eluting stents in…”
Get full text

Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and study design of the randomized TWENTE III multicenter trial by Lam, Ming Kai, MD, Sen, Hanim, MD, Tandjung, Kenneth, MD, van Houwelingen, K. Gert, MD, de Vries, Arie G., MD, Danse, Peter W., MD, PhD, Schotborgh, Carl E., MD, Scholte, Martijn, MD, Löwik, Marije M., PhD, Linssen, Gerard C.M., MD, PhD, IJzerman, Maarten J., PhD, van der Palen, Job, PhD, Doggen, Carine J.M., PhD, von Birgelen, Clemens, MD, PhD

“…Aim To evaluate the safety and efficacy of 2 novel drug-eluting stents (DES) with biodegradable polymer-based coatings versus a durable coating DES. Methods…”
Get full text

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry by Sen, Hanim, Lam, Ming Kai, Tandjung, Kenneth, Löwik, Marije M, van Houwelingen, K. Gert, Stoel, Martin G, Louwerenburg, Hans W, de Man, Frits H.A.F, Linssen, Gerard C.M, Grandjean, Jan G, Doggen, Carine J.M, von Birgelen, Clemens

“…Abstract Background Patients with previous coronary artery bypass grafting (CABG) who underwent percutaneous coronary intervention (PCI) have an increased…”
Get full text